Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Merck (MRK) Downgraded to 'Hold' at Argus Ahead of Organon Spinoff
-
Merck (MRK) PT Raised to $105 at Argus
-
Notable Analyst Rating Changes 04/26: (ROK) (DPS) (APD) Upgraded; (HES) (ABB) (LEAP) Downgraded
-
Notable Analyst Rating Changes 06/04: JOYG, MRK, ORCL, SGMS Upgraded; INFA, HYC, NLC, STP Downgraded
-
Argus Upgrades Merck (MRK) to Buy
-
David Moenning's Daily State of the Markets: 3/13
-
David Moenning's Daily State of the Markets: 2/3

